High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype

Yoel Genaro Montoyo-Pujol; Gloria Peiró

doi:10.21203/rs.3.rs-3903179/v1

High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype

Yoel Genaro Montoyo-Pujol(Instituto de investigación sanitaria y biomédica de Alicante), Gloria Peiró(Hospital General Universitario de Alicante Doctor Balmis)

Research Square

January 31, 2024

10.21203/rs.3.rs-3903179/v1

Cited by 1

|British Journal of Cancer|2014|94

Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome

|Modern Pathology|2004|60

High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype

Related Papers